Tuesday, March 3, 2026 at 10:30 AM
Investors are increasingly wary of the rare-disease space, spooked by a regulatory shift.
Traders are betting investments in the technology won’t pay off as investors become increasingly nervous about AI’s potential impact.
The pause is the vice president’s first action as the new leader of a task force on government fraud.
The S&P 500 and Nasdaq composite fell in February, dragged down by firms whose businesses might be disrupted.
Investors look for more clarity on tech shifts.
Data sourced from public RSS feeds and News APIs.